Amgen: Large biotechnology company focused on oncology, inflammation, and rare diseases.
Price
385.76
24H
—
Volume 24h
$170.11K
OI (USD)
$630.27K
Market Cap
$208.45B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | AMGNSTOCK_USDT | 385.71 | 385.53 | +4.7 bps | +0.00% +0.0000% / 8h · -- | $114.27K | 67.2% | $418.26K | 47d |
 | AMGNUSDT | 385.63 | 385.56 | +1.8 bps | +0.00% +0.0000% / 8h · -- | $42.36K | 24.9% | $63.52K | 48d |
 | AMGN_USDT | 386.50 | 385.63 | +22.6 bps | +0.00% +0.0000% / 8h · -- | $8.9K | 5.2% | $63.12K | 94d |
 | AMGNUSDT | 386.73 | 386.73 | +0.0 bps | +0.00% +0.0000% / 8h · -- | $4.58K | 2.7% | $85.37K | 51d |
News
5AMGN▲AMGN listed on HTX
18dAMGN▲AMGN listed on WEEX
20dAMGN▼FTC conducts antitrust review of Amgen's patent application acquisition deal
29dAMGN▲Amgen raises FY adjusted EPS guidance to $22.30-$23.50 from $21.70-$23.10
×22026-08-04AMGN▲Amgen Q2 revenue $10.05B beats $9.44B est, EPS $6.29 vs $5.62
2026-08-04